University of Copenhagen, Copenhagen, Denmark.
Cancer Epidemiol. 2011 Aug;35(4):381-7. doi: 10.1016/j.canep.2010.10.011. Epub 2010 Dec 10.
We investigated whether breast cancer is predicted by a breast cancer risk mammographic texture resemblance (MTR) marker.
A previously published case-control study included 495 women of which 245 were diagnosed with breast cancer. In baseline mammograms, 2-4 years prior to diagnosis, the following mammographic parameters were analysed for relation to breast cancer risk: (C) categorical parenchymal pattern scores; (R) radiologist's percentage density, (P) computer-based percentage density; (H) computer-based breast cancer risk MTR marker; (E) computer-based hormone replacement treatment MTR marker; and (A) an aggregate of P and H.
Density scores, C, R, and P correlated (tau=0.3-0.6); no other pair of scores showed large (tau>0.2) correlation. For the parameters, the odds ratios of future incidence of breast cancer comparing highest to lowest categories (146 and 106 subject respectively) were C: 2.4(1.4-4.2), R: 2.4(1.4-4.1), P: 2.5(1.5-4.2), E: non-significant, H: 4.2(2.4-7.2), and A: 5.6(3.2-9.8). The AUC analysis showed a similarly increasing pattern (C: 0.58±0.02, R: 0.57±0.03, P: 0.60±0.03, H: 0.63±0.02, A: 0.66±0.02). The AUC of the aggregate marker (A) surpasses others significantly except H. HRT-MTR (E) did not significantly identify future cancers or correlate with any other marker.
Breast cancer risk MTR marker was independent of density scores and more predictive of risk. The hormone replacement treatment MTR marker did not identify patients at risk.
研究乳腺癌风险的乳腺 X 线摄影纹理相似性(MTR)标志物是否可以预测乳腺癌。
一项先前发表的病例对照研究纳入了 495 名女性,其中 245 名被诊断患有乳腺癌。在基线乳腺 X 线摄影中,即在诊断前 2-4 年,分析了以下乳腺 X 线摄影参数与乳腺癌风险的关系:(C)分类实质模式评分;(R)放射科医师的百分比密度;(P)基于计算机的百分比密度;(H)基于计算机的乳腺癌风险 MTR 标志物;(E)基于计算机的激素替代治疗 MTR 标志物;以及(A) P 和 H 的总和。
密度评分 C、R 和 P 呈正相关(tau=0.3-0.6);没有其他两个评分表现出较大的相关性(tau>0.2)。对于这些参数,比较最高和最低分类的未来乳腺癌发病的比值比(分别为 146 和 106 例)为 C:2.4(1.4-4.2)、R:2.4(1.4-4.1)、P:2.5(1.5-4.2)、E:无显著性、H:4.2(2.4-7.2)和 A:5.6(3.2-9.8)。AUC 分析显示出相似的递增模式(C:0.58±0.02、R:0.57±0.03、P:0.60±0.03、H:0.63±0.02、A:0.66±0.02)。集合标志物(A)的 AUC 明显优于其他标志物,除了 H。激素替代治疗 MTR 标志物(E)不能显著识别未来的癌症,也与其他任何标志物没有相关性。
乳腺癌风险 MTR 标志物独立于密度评分,对风险的预测更具预测性。激素替代治疗 MTR 标志物不能识别有风险的患者。